Cancer remains a major health issue worldwide. Treatment of local disease has advanced significantly, but systemic, metastasized disease remains an important challenge.
Small molecules and immunotherapy are promising but only for a small percentage of patients.
We strive for the highest possible reliability and quality of our products. Our wish is to be recognized as “best-in-class” for the delivery of high-quality innovative products which we offer to our partners as a commercial opportunity. We aspire a good long-term strategic collaboration with all our partners.
We intend to make a reasonable profit from our business activities, so that we can meet our commitments, continue our growth and achieve our goals.
Our mission encourages us to contribute to human well-being and to our community, which also includes environment friendly measures. We strive to develop products that have a minimal impact on the environment in terms of design, raw materials, production, packaging, recycling and waste disposal.
Strong values define our corporate culture and help us fulfill ElmediX’ mission and vision.
As a company, we want to represent a stable, caring and reliable partner for all our stakeholders: patients, healthcare providers and hospitals, suppliers, employees and shareholders.
We strive to take our responsibilities as a company with a high sense of citizenship. It promotes respect, fairness, transparency and justice with which we lead our professional practices and determines our positive contribution to society.
As a team, we work constructively together on the same goal in an open positive atmosphere, with respect for each other, striving for a pleasant, motivating and inspiring working environment.
Commitment, taking responsibility, initiative and continuous improvement are deeply embedded in our corporate culture.
Johan graduated from KUL as Electrotechnical engineer and worked on a PhD in robotics at PMA, Leuven and NIST, Washington DC.
Oleg worked in anesthesiology at Antwerp University Hospital.
Oleg was Clinical research physician at SGS until he started at ElmediX.
As a hands-on and achievement oriented person, her focus is on implementing, improving and supporting a functional finance reporting and analysis system, in alignment with the goals and mission of the company.
Carine joined ElmediX in December 2019.
Chairman of Pancreatic Cancer Expert Committee of Chinese Society of Clinical Oncology, Committee of Oncology Branch of Chinese Medical Association and Group Leader of Pancreatic Oncology, Vice Chairman of the Pancreatic Disease Professional Committee of the Chinese Research Hospital Association.
Presided over the first “Chinese Expert Consensus on the Diagnosis and Treatment of Pancreatic Cancer” and the first “CSCO Guidelines for Pancreatic Cancer Diagnosis and Treatment” of the Chinese Society of Clinical Oncology.
The associate editor of “Journal of Pancreatology”, the editorial board member of “Cancer Research”, “JHO”, “Tumor”, “Clinical Oncology” and other journals.
Published more than 100 SCI papers with more than 1,000 times citation.
Since its inception in 2015, ElmediX has brought together a highly skilled team. In the (near) future, our team will be expanded with other enthusiastic colleagues. Interested in joining the team? See our current vacancies.